Medical Devices Africa

Africa Hepatitis Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Africa Hepatitis Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Virus, Test, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Africa · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $64.5 Mn Placeholder estimate
Estimate 2025 $68.7 Mn 1.4% of the global market
Projected 2034 $121.1 Mn 76.3% Adds $52.4 Mn over 9 forecast years
CAGR 2025–2034 6.5% Faster than 3% of 173 Medical Devices markets here
Key players 5
  • Africa is 1.39% of the global market.
  • Among regions, the largest is North America at $2.80 Bn.
  • Fastest growing: Africa (this report) at 6.5% a year.
  • Africa ranks 6th of 6 by size among regions.

Market size projection

Africa

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$52.4 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Hepatitis Diagnostics Market market size by year, Africa
YearMarket sizeChange that yearSince 2025
2024 (estimate) $64.5 Mn — —
2025 (base) $68.7 Mn +$4.2 Mn —
2026 (forecast) $73.2 Mn +$4.5 Mn +6.5%
2027 (forecast) $78.0 Mn +$4.8 Mn +13.4%
2028 (forecast) $83.0 Mn +$5.1 Mn +20.8%
2029 (forecast) $88.4 Mn +$5.4 Mn +28.6%
2030 (forecast) $94.2 Mn +$5.7 Mn +37%
2031 (forecast) $100.3 Mn +$6.1 Mn +45.9%
2032 (forecast) $106.8 Mn +$6.5 Mn +55.4%
2033 (forecast) $113.8 Mn +$6.9 Mn +65.5%
2034 (forecast) $121.1 Mn +$7.4 Mn +76.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Africa Hepatitis Diagnostics Market Analysis at a glance
Market size, 2025$68.7 Mn placeholder estimate
Forecast, 2034$121.1 Mn placeholder estimate
Growth (CAGR), 2025–20346.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsVirus, test and end user (see all)
Key playersAbbott Laboratories, Roche Diagnostics, Siemens Healthineers, Cepheid, OraSure Technologies (see all)
Regulator in AfricaAMASource: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
Active clinical trials20 in AfricaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Africa Hepatitis Diagnostics Market Analysis Executive Summary

Hepatitis diagnostics detect hepatitis B and C infections and measure virus levels to guide treatment.

Key segments of the hepatitis Diagnostics market include virus (Hepatitis B, Hepatitis C and Hepatitis A) and test (Immunoassays, Molecular Tests and Rapid Tests).

Bar chart: Africa Hepatitis Diagnostics market size, 2024–2034, placeholder estimates. $64.5 Mn in 2024, $68.7 Mn in 2025 and $121.1 Mn in 2034, 6.5% CAGR.
Africa Hepatitis Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Africa Hepatitis Diagnostics Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the hepatitis Diagnostics market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the hepatitis Diagnostics market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the hepatitis Diagnostics market.

Competitive Landscape for Hepatitis Diagnostics Market in Africa

The hepatitis Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Hepatitis Diagnostics Market in Africa

Hepatitis Diagnostics in Africa: rules, payment and research

The African Medicines Agency (AMA) treaty covers medical devices and diagnostics as well as medicines; national regulators still approve products.⁠[1] In some of the countries we cover here, medical devices are regulated by EDA (Egypt)⁠[2], PPB (Kenya)⁠[3] and SAHPRA (South Africa)⁠[4]. How care is paid for in some of these countries: universal health insurance (Egypt)⁠[5], the SHA (Kenya)⁠[6] and planned National Health Insurance (South Africa)⁠[7]. ClinicalTrials.gov lists 20 studies on Hepatitis Diagnostics that are recruiting, active or about to start in Africa.⁠[8]

[1] African Union, African Medicines Agency treaty. Checked 14 Nov 2026.

[2] Egyptian Drug Authority. Checked 14 Nov 2026.

[3] Pharmacy and Poisons Board. Checked 14 Nov 2026.

[4] South African Health Products Regulatory Authority. Checked 14 Nov 2026.

[5] Universal Health Insurance Authority. Checked 14 Nov 2026.

[6] Social Health Authority. Checked 14 Nov 2026.

[7] National Department of Health. Checked 14 Nov 2026.

[8] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hepatitis Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Africa.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Hepatitis Diagnostics right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Hepatitis Diagnostics in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Hepatitis Diagnostics market in Africa?
Placeholder estimate: about $68.7 Mn in 2025, rising to about $121.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Hepatitis Diagnostics market in Africa growing?
Placeholder estimate: about 6.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Hepatitis Diagnostics market report cover?
The report splits the market by virus (Hepatitis B, Hepatitis C, Hepatitis A, Hepatitis D and E), test (Immunoassays, Molecular Tests, Rapid Tests) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Hepatitis Diagnostics market?
Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Cepheid and OraSure Technologies.
What is driving the Hepatitis Diagnostics market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the hepatitis Diagnostics market.
Who regulates Hepatitis Diagnostics in Africa?
The African Medicines Agency (AMA) treaty covers medical devices and diagnostics as well as medicines; national regulators still approve products. Source: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
How many clinical trials on Hepatitis Diagnostics are running in Africa?
20 studies are recruiting, active or about to start in Africa, counted across the 17 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.
How much research is published on Hepatitis Diagnostics?
PubMed lists 22,916 papers on Hepatitis Diagnostics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Africa

See all

Related on diagnostics and lab testing and hepatitis

See the topic